nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextrothyroxine—SLC7A5—Melphalan—ovarian cancer	0.779	1	CbGbCtD
Dextrothyroxine—TPO—Thyroxine (Thyroid Hormone) Production—TG—ovarian cancer	0.0215	0.257	CbGpPWpGaD
Dextrothyroxine—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—ovarian cancer	0.00653	0.078	CbGpPWpGaD
Dextrothyroxine—TPO—Thyroxine biosynthesis—SLC5A5—ovarian cancer	0.00518	0.062	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—NR5A1—ovarian cancer	0.00317	0.0379	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—NR5A1—ovarian cancer	0.00317	0.0379	CbGpPWpGaD
Dextrothyroxine—TPO—Amine-derived hormones—SLC5A5—ovarian cancer	0.00298	0.0356	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00251	0.0299	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00251	0.0299	CbGpPWpGaD
Dextrothyroxine—TPO—testis—ovarian cancer	0.00245	0.0414	CbGeAlD
Dextrothyroxine—SLC7A5—myometrium—ovarian cancer	0.00243	0.0411	CbGeAlD
Dextrothyroxine—SLCO4C1—endometrium—ovarian cancer	0.00234	0.0395	CbGeAlD
Dextrothyroxine—SLCO4A1—myometrium—ovarian cancer	0.00212	0.0359	CbGeAlD
Dextrothyroxine—THRB—gonad—ovarian cancer	0.00208	0.0351	CbGeAlD
Dextrothyroxine—THRA—gonad—ovarian cancer	0.00208	0.0351	CbGeAlD
Dextrothyroxine—SLC7A5—epithelium—ovarian cancer	0.00191	0.0322	CbGeAlD
Dextrothyroxine—SLC7A5—uterine cervix—ovarian cancer	0.00189	0.032	CbGeAlD
Dextrothyroxine—THRB—female reproductive system—ovarian cancer	0.00186	0.0314	CbGeAlD
Dextrothyroxine—THRA—female reproductive system—ovarian cancer	0.00186	0.0314	CbGeAlD
Dextrothyroxine—SLCO4C1—bone marrow—ovarian cancer	0.00183	0.0309	CbGeAlD
Dextrothyroxine—SLC7A5—decidua—ovarian cancer	0.0018	0.0305	CbGeAlD
Dextrothyroxine—SLCO4C1—vagina—ovarian cancer	0.00175	0.0296	CbGeAlD
Dextrothyroxine—SLC7A5—endometrium—ovarian cancer	0.00171	0.0289	CbGeAlD
Dextrothyroxine—THRA—female gonad—ovarian cancer	0.00169	0.0286	CbGeAlD
Dextrothyroxine—THRB—female gonad—ovarian cancer	0.00169	0.0286	CbGeAlD
Dextrothyroxine—THRB—vagina—ovarian cancer	0.00168	0.0284	CbGeAlD
Dextrothyroxine—SLC7A5—gonad—ovarian cancer	0.00159	0.0268	CbGeAlD
Dextrothyroxine—THRB—Nuclear Receptors—PGR—ovarian cancer	0.00158	0.0189	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—PGR—ovarian cancer	0.00158	0.0189	CbGpPWpGaD
Dextrothyroxine—SLC7A5—uterus—ovarian cancer	0.00158	0.0266	CbGeAlD
Dextrothyroxine—SLCO4A1—decidua—ovarian cancer	0.00158	0.0266	CbGeAlD
Dextrothyroxine—THRB—testis—ovarian cancer	0.0015	0.0253	CbGeAlD
Dextrothyroxine—THRA—testis—ovarian cancer	0.0015	0.0253	CbGeAlD
Dextrothyroxine—SLCO4A1—endometrium—ovarian cancer	0.0015	0.0252	CbGeAlD
Dextrothyroxine—SLC7A5—female reproductive system—ovarian cancer	0.00142	0.0239	CbGeAlD
Dextrothyroxine—SLC7A5—bone marrow—ovarian cancer	0.00134	0.0226	CbGeAlD
Dextrothyroxine—SLC7A5—female gonad—ovarian cancer	0.00129	0.0218	CbGeAlD
Dextrothyroxine—SLC7A5—vagina—ovarian cancer	0.00128	0.0217	CbGeAlD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00125	0.0149	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00125	0.0149	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—testis—ovarian cancer	0.00125	0.0211	CbGeAlD
Dextrothyroxine—SLCO4A1—female reproductive system—ovarian cancer	0.00124	0.0209	CbGeAlD
Dextrothyroxine—SLC7A5—testis—ovarian cancer	0.00114	0.0193	CbGeAlD
Dextrothyroxine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00114	0.0136	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—vagina—ovarian cancer	0.00112	0.0189	CbGeAlD
Dextrothyroxine—SLCO1B1—female reproductive system—ovarian cancer	0.00109	0.0184	CbGeAlD
Dextrothyroxine—THRA—lymph node—ovarian cancer	0.00109	0.0184	CbGeAlD
Dextrothyroxine—THRB—lymph node—ovarian cancer	0.00109	0.0184	CbGeAlD
Dextrothyroxine—SLC7A5—Basigin interactions—CAV1—ovarian cancer	0.00104	0.0124	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC5A5—ovarian cancer	0.00101	0.012	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—testis—ovarian cancer	0.001	0.0169	CbGeAlD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00098	0.0117	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—lymph node—ovarian cancer	0.000904	0.0153	CbGeAlD
Dextrothyroxine—THRB—Nuclear Receptors—ESR1—ovarian cancer	0.000843	0.0101	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—ESR1—ovarian cancer	0.000843	0.0101	CbGpPWpGaD
Dextrothyroxine—SLC7A5—lymph node—ovarian cancer	0.00083	0.014	CbGeAlD
Dextrothyroxine—SLCO4A1—lymph node—ovarian cancer	0.000725	0.0122	CbGeAlD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.000666	0.00796	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.000666	0.00796	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000624	0.00745	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.000592	0.00708	CbGpPWpGaD
Dextrothyroxine—Dysphagia—Vinorelbine—ovarian cancer	0.000572	0.00741	CcSEcCtD
Dextrothyroxine—Sweating—Topotecan—ovarian cancer	0.000571	0.0074	CcSEcCtD
Dextrothyroxine—Angina pectoris—Vinorelbine—ovarian cancer	0.000557	0.00721	CcSEcCtD
Dextrothyroxine—Alopecia—Chlorambucil—ovarian cancer	0.000531	0.00688	CcSEcCtD
Dextrothyroxine—SLCO1B1—Irinotecan Pathway—APC—ovarian cancer	0.000525	0.00628	CbGpPWpGaD
Dextrothyroxine—Weight decreased—Vinorelbine—ovarian cancer	0.000517	0.0067	CcSEcCtD
Dextrothyroxine—Levothyroxine—ABCB1—ovarian cancer	0.00051	0.372	CrCbGaD
Dextrothyroxine—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.000503	0.00651	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Vinorelbine—ovarian cancer	0.0005	0.00647	CcSEcCtD
Dextrothyroxine—Liotrix—ABCB1—ovarian cancer	0.000498	0.363	CrCbGaD
Dextrothyroxine—Cardiac failure congestive—Paclitaxel—ovarian cancer	0.000491	0.00636	CcSEcCtD
Dextrothyroxine—Tremor—Chlorambucil—ovarian cancer	0.00049	0.00635	CcSEcCtD
Dextrothyroxine—Flushing—Melphalan—ovarian cancer	0.000486	0.0063	CcSEcCtD
Dextrothyroxine—Agitation—Chlorambucil—ovarian cancer	0.000481	0.00623	CcSEcCtD
Dextrothyroxine—Angioedema—Chlorambucil—ovarian cancer	0.000478	0.00619	CcSEcCtD
Dextrothyroxine—Alopecia—Topotecan—ovarian cancer	0.000473	0.00612	CcSEcCtD
Dextrothyroxine—Arrhythmia—Melphalan—ovarian cancer	0.000468	0.00606	CcSEcCtD
Dextrothyroxine—Alopecia—Melphalan—ovarian cancer	0.000463	0.006	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Paclitaxel—ovarian cancer	0.000456	0.00591	CcSEcCtD
Dextrothyroxine—Cardiac failure—Paclitaxel—ovarian cancer	0.000456	0.00591	CcSEcCtD
Dextrothyroxine—Convulsion—Chlorambucil—ovarian cancer	0.000453	0.00587	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000433	0.00517	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000433	0.00517	CbGpPWpGaD
Dextrothyroxine—Confusional state—Chlorambucil—ovarian cancer	0.00043	0.00558	CcSEcCtD
Dextrothyroxine—Angioedema—Topotecan—ovarian cancer	0.000426	0.00551	CcSEcCtD
Dextrothyroxine—Flushing—Vinorelbine—ovarian cancer	0.000425	0.0055	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Paclitaxel—ovarian cancer	0.000423	0.00548	CcSEcCtD
Dextrothyroxine—Mood swings—Paclitaxel—ovarian cancer	0.000422	0.00546	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000418	0.005	CbGpPWpGaD
Dextrothyroxine—Cardiac failure congestive—Docetaxel—ovarian cancer	0.000416	0.00539	CcSEcCtD
Dextrothyroxine—TPO—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.000415	0.00496	CbGpPWpGaD
Dextrothyroxine—Dehydration—Paclitaxel—ovarian cancer	0.000414	0.00536	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000409	0.00489	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Vinorelbine—ovarian cancer	0.000409	0.0053	CcSEcCtD
Dextrothyroxine—TPO—Differentiation Pathway—VEGFA—ovarian cancer	0.000406	0.00486	CbGpPWpGaD
Dextrothyroxine—Alopecia—Vinorelbine—ovarian cancer	0.000404	0.00524	CcSEcCtD
Dextrothyroxine—Arthralgia—Topotecan—ovarian cancer	0.000396	0.00514	CcSEcCtD
Dextrothyroxine—Convulsion—Melphalan—ovarian cancer	0.000395	0.00512	CcSEcCtD
Dextrothyroxine—Muscular weakness—Paclitaxel—ovarian cancer	0.000392	0.00508	CcSEcCtD
Dextrothyroxine—Cardiac failure—Docetaxel—ovarian cancer	0.000386	0.00501	CcSEcCtD
Dextrothyroxine—Dysphagia—Paclitaxel—ovarian cancer	0.000385	0.00498	CcSEcCtD
Dextrothyroxine—Sweating increased—Paclitaxel—ovarian cancer	0.000375	0.00485	CcSEcCtD
Dextrothyroxine—Fatigue—Chlorambucil—ovarian cancer	0.000368	0.00477	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Topotecan—ovarian cancer	0.000367	0.00476	CcSEcCtD
Dextrothyroxine—Angioedema—Vinorelbine—ovarian cancer	0.000364	0.00472	CcSEcCtD
Dextrothyroxine—Liothyronine—ABCB1—ovarian cancer	0.000364	0.265	CrCbGaD
Dextrothyroxine—Tachycardia—Melphalan—ovarian cancer	0.000363	0.0047	CcSEcCtD
Dextrothyroxine—Palpitations—Vinorelbine—ovarian cancer	0.000352	0.00456	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000352	0.00456	CcSEcCtD
Dextrothyroxine—Dehydration—Docetaxel—ovarian cancer	0.000351	0.00454	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—MMP9—ovarian cancer	0.00035	0.00418	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000349	0.00452	CcSEcCtD
Dextrothyroxine—Weight decreased—Paclitaxel—ovarian cancer	0.000348	0.00451	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000346	0.00449	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—CAV1—ovarian cancer	0.000346	0.00413	CbGpPWpGaD
Dextrothyroxine—Urticaria—Chlorambucil—ovarian cancer	0.000339	0.00439	CcSEcCtD
Dextrothyroxine—Arthralgia—Vinorelbine—ovarian cancer	0.000339	0.00439	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000339	0.00439	CcSEcCtD
Dextrothyroxine—Dyspnoea—Topotecan—ovarian cancer	0.000339	0.00439	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000338	0.00438	CcSEcCtD
Dextrothyroxine—Body temperature increased—Chlorambucil—ovarian cancer	0.000338	0.00437	CcSEcCtD
Dextrothyroxine—Abdominal pain—Chlorambucil—ovarian cancer	0.000338	0.00437	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Paclitaxel—ovarian cancer	0.000336	0.00435	CcSEcCtD
Dextrothyroxine—Dyspnoea—Melphalan—ovarian cancer	0.000332	0.0043	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—RAD51C—ovarian cancer	0.000331	0.00395	CbGpPWpGaD
Dextrothyroxine—Fatigue—Topotecan—ovarian cancer	0.000328	0.00424	CcSEcCtD
Dextrothyroxine—Dysphagia—Docetaxel—ovarian cancer	0.000326	0.00422	CcSEcCtD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—IL6—ovarian cancer	0.000325	0.00389	CbGpPWpGaD
Dextrothyroxine—Fatigue—Melphalan—ovarian cancer	0.000321	0.00416	CcSEcCtD
Dextrothyroxine—Coma—Epirubicin—ovarian cancer	0.00032	0.00415	CcSEcCtD
Dextrothyroxine—Angina pectoris—Docetaxel—ovarian cancer	0.000318	0.00411	CcSEcCtD
Dextrothyroxine—Tachycardia—Vinorelbine—ovarian cancer	0.000317	0.00411	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—VEGFA—ovarian cancer	0.000314	0.00375	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Topotecan—ovarian cancer	0.000313	0.00406	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000313	0.00374	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000311	0.00403	CcSEcCtD
Dextrothyroxine—Asthenia—Chlorambucil—ovarian cancer	0.000306	0.00397	CcSEcCtD
Dextrothyroxine—Pruritus—Chlorambucil—ovarian cancer	0.000302	0.00391	CcSEcCtD
Dextrothyroxine—Urticaria—Topotecan—ovarian cancer	0.000302	0.00391	CcSEcCtD
Dextrothyroxine—Body temperature increased—Topotecan—ovarian cancer	0.0003	0.00389	CcSEcCtD
Dextrothyroxine—Abdominal pain—Topotecan—ovarian cancer	0.0003	0.00389	CcSEcCtD
Dextrothyroxine—Coma—Doxorubicin—ovarian cancer	0.000296	0.00384	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000296	0.00384	CcSEcCtD
Dextrothyroxine—Urticaria—Melphalan—ovarian cancer	0.000296	0.00383	CcSEcCtD
Dextrothyroxine—Weight decreased—Docetaxel—ovarian cancer	0.000295	0.00382	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—WDR77—ovarian cancer	0.000292	0.00349	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—WDR77—ovarian cancer	0.000292	0.00349	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Chlorambucil—ovarian cancer	0.000292	0.00378	CcSEcCtD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000291	0.00348	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000291	0.00348	CbGpPWpGaD
Dextrothyroxine—Dyspnoea—Vinorelbine—ovarian cancer	0.00029	0.00375	CcSEcCtD
Dextrothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000289	0.00346	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000289	0.00346	CbGpPWpGaD
Dextrothyroxine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000287	0.00371	CcSEcCtD
Dextrothyroxine—Flushing—Paclitaxel—ovarian cancer	0.000286	0.0037	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Docetaxel—ovarian cancer	0.000285	0.00369	CcSEcCtD
Dextrothyroxine—TPO—Differentiation Pathway—IL6—ovarian cancer	0.000281	0.00336	CbGpPWpGaD
Dextrothyroxine—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000281	0.00363	CcSEcCtD
Dextrothyroxine—Fatigue—Vinorelbine—ovarian cancer	0.00028	0.00363	CcSEcCtD
Dextrothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000279	0.00334	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000279	0.00334	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000279	0.00333	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000279	0.00333	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Paclitaxel—ovarian cancer	0.000275	0.00356	CcSEcCtD
Dextrothyroxine—Asthenia—Topotecan—ovarian cancer	0.000273	0.00353	CcSEcCtD
Dextrothyroxine—Alopecia—Paclitaxel—ovarian cancer	0.000272	0.00352	CcSEcCtD
Dextrothyroxine—Vomiting—Chlorambucil—ovarian cancer	0.000271	0.00352	CcSEcCtD
Dextrothyroxine—Increased appetite—Epirubicin—ovarian cancer	0.000271	0.00351	CcSEcCtD
Dextrothyroxine—Pruritus—Topotecan—ovarian cancer	0.000269	0.00348	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000268	0.00347	CcSEcCtD
Dextrothyroxine—Asthenia—Melphalan—ovarian cancer	0.000267	0.00346	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000266	0.00318	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000266	0.00344	CcSEcCtD
Dextrothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000265	0.00316	CbGpPWpGaD
Dextrothyroxine—Pruritus—Melphalan—ovarian cancer	0.000263	0.00341	CcSEcCtD
Dextrothyroxine—Tension—Paclitaxel—ovarian cancer	0.000263	0.00341	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Epirubicin—ovarian cancer	0.000261	0.00338	CcSEcCtD
Dextrothyroxine—Cardiac failure—Epirubicin—ovarian cancer	0.000261	0.00338	CcSEcCtD
Dextrothyroxine—Nervousness—Paclitaxel—ovarian cancer	0.00026	0.00337	CcSEcCtD
Dextrothyroxine—Diarrhoea—Topotecan—ovarian cancer	0.00026	0.00337	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00026	0.00336	CcSEcCtD
Dextrothyroxine—Urticaria—Vinorelbine—ovarian cancer	0.000258	0.00335	CcSEcCtD
Dextrothyroxine—Body temperature increased—Vinorelbine—ovarian cancer	0.000257	0.00333	CcSEcCtD
Dextrothyroxine—Abdominal pain—Vinorelbine—ovarian cancer	0.000257	0.00333	CcSEcCtD
Dextrothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000256	0.00306	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000255	0.00305	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Melphalan—ovarian cancer	0.000255	0.0033	CcSEcCtD
Dextrothyroxine—Nausea—Chlorambucil—ovarian cancer	0.000254	0.00328	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—NME2—ovarian cancer	0.000251	0.003	CbGpPWpGaD
Dextrothyroxine—Tremor—Paclitaxel—ovarian cancer	0.000251	0.00325	CcSEcCtD
Dextrothyroxine—Increased appetite—Doxorubicin—ovarian cancer	0.000251	0.00325	CcSEcCtD
Dextrothyroxine—Affect lability—Epirubicin—ovarian cancer	0.00025	0.00324	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—YAP1—ovarian cancer	0.000247	0.00295	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—YAP1—ovarian cancer	0.000247	0.00295	CbGpPWpGaD
Dextrothyroxine—Agitation—Paclitaxel—ovarian cancer	0.000246	0.00319	CcSEcCtD
Dextrothyroxine—Angioedema—Paclitaxel—ovarian cancer	0.000245	0.00317	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000244	0.00291	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000243	0.0029	CbGpPWpGaD
Dextrothyroxine—Flushing—Docetaxel—ovarian cancer	0.000242	0.00314	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Epirubicin—ovarian cancer	0.000242	0.00313	CcSEcCtD
Dextrothyroxine—Vomiting—Topotecan—ovarian cancer	0.000242	0.00313	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PIK3CB—ovarian cancer	0.000241	0.00288	CbGpPWpGaD
Dextrothyroxine—Cardiac failure—Doxorubicin—ovarian cancer	0.000241	0.00312	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000241	0.00312	CcSEcCtD
Dextrothyroxine—Mood swings—Epirubicin—ovarian cancer	0.000241	0.00312	CcSEcCtD
Dextrothyroxine—Rash—Topotecan—ovarian cancer	0.00024	0.0031	CcSEcCtD
Dextrothyroxine—Dermatitis—Topotecan—ovarian cancer	0.000239	0.0031	CcSEcCtD
Dextrothyroxine—Headache—Topotecan—ovarian cancer	0.000238	0.00308	CcSEcCtD
Dextrothyroxine—Palpitations—Paclitaxel—ovarian cancer	0.000237	0.00307	CcSEcCtD
Dextrothyroxine—Vomiting—Melphalan—ovarian cancer	0.000237	0.00306	CcSEcCtD
Dextrothyroxine—Dehydration—Epirubicin—ovarian cancer	0.000237	0.00306	CcSEcCtD
Dextrothyroxine—Rash—Melphalan—ovarian cancer	0.000235	0.00304	CcSEcCtD
Dextrothyroxine—Dermatitis—Melphalan—ovarian cancer	0.000234	0.00304	CcSEcCtD
Dextrothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000234	0.0028	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000234	0.00279	CbGpPWpGaD
Dextrothyroxine—Asthenia—Vinorelbine—ovarian cancer	0.000233	0.00302	CcSEcCtD
Dextrothyroxine—Arrhythmia—Docetaxel—ovarian cancer	0.000233	0.00302	CcSEcCtD
Dextrothyroxine—Convulsion—Paclitaxel—ovarian cancer	0.000232	0.00301	CcSEcCtD
Dextrothyroxine—Affect lability—Doxorubicin—ovarian cancer	0.000232	0.003	CcSEcCtD
Dextrothyroxine—Alopecia—Docetaxel—ovarian cancer	0.000231	0.00299	CcSEcCtD
Dextrothyroxine—Pruritus—Vinorelbine—ovarian cancer	0.00023	0.00298	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—TTF1—ovarian cancer	0.000229	0.00274	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—TTF1—ovarian cancer	0.000229	0.00274	CbGpPWpGaD
Dextrothyroxine—Arthralgia—Paclitaxel—ovarian cancer	0.000228	0.00295	CcSEcCtD
Dextrothyroxine—Anxiety—Paclitaxel—ovarian cancer	0.000227	0.00294	CcSEcCtD
Dextrothyroxine—Nausea—Topotecan—ovarian cancer	0.000226	0.00292	CcSEcCtD
Dextrothyroxine—Muscular weakness—Epirubicin—ovarian cancer	0.000224	0.00291	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000224	0.0029	CcSEcCtD
Dextrothyroxine—Mood swings—Doxorubicin—ovarian cancer	0.000223	0.00289	CcSEcCtD
Dextrothyroxine—Diarrhoea—Vinorelbine—ovarian cancer	0.000222	0.00288	CcSEcCtD
Dextrothyroxine—Nausea—Melphalan—ovarian cancer	0.000221	0.00286	CcSEcCtD
Dextrothyroxine—Confusional state—Paclitaxel—ovarian cancer	0.000221	0.00286	CcSEcCtD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00022	0.00263	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00022	0.00263	CbGpPWpGaD
Dextrothyroxine—Dysphagia—Epirubicin—ovarian cancer	0.00022	0.00285	CcSEcCtD
Dextrothyroxine—Dehydration—Doxorubicin—ovarian cancer	0.000219	0.00284	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—PGR—ovarian cancer	0.000216	0.00258	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—PGR—ovarian cancer	0.000216	0.00258	CbGpPWpGaD
Dextrothyroxine—Shock—Paclitaxel—ovarian cancer	0.000215	0.00279	CcSEcCtD
Dextrothyroxine—Angina pectoris—Epirubicin—ovarian cancer	0.000214	0.00277	CcSEcCtD
Dextrothyroxine—Tachycardia—Paclitaxel—ovarian cancer	0.000213	0.00276	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000211	0.00274	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—NR5A1—ovarian cancer	0.000208	0.00249	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—NR5A1—ovarian cancer	0.000208	0.00249	CbGpPWpGaD
Dextrothyroxine—Muscular weakness—Doxorubicin—ovarian cancer	0.000208	0.00269	CcSEcCtD
Dextrothyroxine—Vomiting—Vinorelbine—ovarian cancer	0.000207	0.00268	CcSEcCtD
Dextrothyroxine—Rash—Vinorelbine—ovarian cancer	0.000205	0.00266	CcSEcCtD
Dextrothyroxine—Dermatitis—Vinorelbine—ovarian cancer	0.000205	0.00265	CcSEcCtD
Dextrothyroxine—Headache—Vinorelbine—ovarian cancer	0.000204	0.00264	CcSEcCtD
Dextrothyroxine—Dysphagia—Doxorubicin—ovarian cancer	0.000203	0.00264	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000202	0.00241	CbGpPWpGaD
Dextrothyroxine—Palpitations—Docetaxel—ovarian cancer	0.000201	0.0026	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—AKT1—ovarian cancer	0.0002	0.00239	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—PARP1—ovarian cancer	0.0002	0.00239	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—PARP1—ovarian cancer	0.0002	0.00239	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000199	0.00258	CcSEcCtD
Dextrothyroxine—Weight decreased—Epirubicin—ovarian cancer	0.000199	0.00258	CcSEcCtD
Dextrothyroxine—Angina pectoris—Doxorubicin—ovarian cancer	0.000198	0.00257	CcSEcCtD
Dextrothyroxine—Insomnia—Paclitaxel—ovarian cancer	0.000198	0.00256	CcSEcCtD
Dextrothyroxine—Convulsion—Docetaxel—ovarian cancer	0.000197	0.00255	CcSEcCtD
Dextrothyroxine—Dyspnoea—Paclitaxel—ovarian cancer	0.000195	0.00253	CcSEcCtD
Dextrothyroxine—Arthralgia—Docetaxel—ovarian cancer	0.000193	0.0025	CcSEcCtD
Dextrothyroxine—Nausea—Vinorelbine—ovarian cancer	0.000193	0.0025	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.00019	0.00227	CbGpPWpGaD
Dextrothyroxine—Fatigue—Paclitaxel—ovarian cancer	0.000189	0.00244	CcSEcCtD
Dextrothyroxine—Sweating—Epirubicin—ovarian cancer	0.000188	0.00243	CcSEcCtD
Dextrothyroxine—Confusional state—Docetaxel—ovarian cancer	0.000187	0.00242	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.000186	0.00222	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000185	0.00221	CbGpPWpGaD
Dextrothyroxine—Weight decreased—Doxorubicin—ovarian cancer	0.000184	0.00238	CcSEcCtD
Dextrothyroxine—Shock—Docetaxel—ovarian cancer	0.000182	0.00236	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000181	0.00217	CbGpPWpGaD
Dextrothyroxine—Tachycardia—Docetaxel—ovarian cancer	0.000181	0.00234	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00018	0.00233	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000179	0.00232	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—SPARC—ovarian cancer	0.000176	0.00211	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000175	0.00209	CbGpPWpGaD
Dextrothyroxine—Sweating—Doxorubicin—ovarian cancer	0.000174	0.00225	CcSEcCtD
Dextrothyroxine—Urticaria—Paclitaxel—ovarian cancer	0.000174	0.00225	CcSEcCtD
Dextrothyroxine—Body temperature increased—Paclitaxel—ovarian cancer	0.000173	0.00224	CcSEcCtD
Dextrothyroxine—Abdominal pain—Paclitaxel—ovarian cancer	0.000173	0.00224	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000169	0.00219	CcSEcCtD
Dextrothyroxine—Insomnia—Docetaxel—ovarian cancer	0.000168	0.00217	CcSEcCtD
Dextrothyroxine—Dyspnoea—Docetaxel—ovarian cancer	0.000165	0.00214	CcSEcCtD
Dextrothyroxine—Flushing—Epirubicin—ovarian cancer	0.000163	0.00212	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—CYTB—ovarian cancer	0.000162	0.00194	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.00016	0.00191	CbGpPWpGaD
Dextrothyroxine—Fatigue—Docetaxel—ovarian cancer	0.00016	0.00207	CcSEcCtD
Dextrothyroxine—Arrhythmia—Epirubicin—ovarian cancer	0.000157	0.00204	CcSEcCtD
Dextrothyroxine—Asthenia—Paclitaxel—ovarian cancer	0.000157	0.00203	CcSEcCtD
Dextrothyroxine—Alopecia—Epirubicin—ovarian cancer	0.000156	0.00201	CcSEcCtD
Dextrothyroxine—Pruritus—Paclitaxel—ovarian cancer	0.000155	0.002	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000154	0.00184	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Docetaxel—ovarian cancer	0.000153	0.00198	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000152	0.00196	CcSEcCtD
Dextrothyroxine—Flushing—Doxorubicin—ovarian cancer	0.000151	0.00196	CcSEcCtD
Dextrothyroxine—Tension—Epirubicin—ovarian cancer	0.00015	0.00195	CcSEcCtD
Dextrothyroxine—Diarrhoea—Paclitaxel—ovarian cancer	0.00015	0.00194	CcSEcCtD
Dextrothyroxine—Nervousness—Epirubicin—ovarian cancer	0.000149	0.00193	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.000147	0.00176	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000147	0.00176	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000147	0.00176	CbGpPWpGaD
Dextrothyroxine—Abdominal pain—Docetaxel—ovarian cancer	0.000147	0.0019	CcSEcCtD
Dextrothyroxine—Body temperature increased—Docetaxel—ovarian cancer	0.000147	0.0019	CcSEcCtD
Dextrothyroxine—Arrhythmia—Doxorubicin—ovarian cancer	0.000145	0.00188	CcSEcCtD
Dextrothyroxine—Alopecia—Doxorubicin—ovarian cancer	0.000144	0.00186	CcSEcCtD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000142	0.0017	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000142	0.0017	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—BRIP1—ovarian cancer	0.000142	0.00169	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PPP1CC—ovarian cancer	0.000142	0.00169	CbGpPWpGaD
Dextrothyroxine—Agitation—Epirubicin—ovarian cancer	0.000141	0.00182	CcSEcCtD
Dextrothyroxine—Tension—Doxorubicin—ovarian cancer	0.000139	0.0018	CcSEcCtD
Dextrothyroxine—Vomiting—Paclitaxel—ovarian cancer	0.000139	0.0018	CcSEcCtD
Dextrothyroxine—Rash—Paclitaxel—ovarian cancer	0.000138	0.00179	CcSEcCtD
Dextrothyroxine—Dermatitis—Paclitaxel—ovarian cancer	0.000138	0.00178	CcSEcCtD
Dextrothyroxine—Nervousness—Doxorubicin—ovarian cancer	0.000138	0.00178	CcSEcCtD
Dextrothyroxine—Headache—Paclitaxel—ovarian cancer	0.000137	0.00177	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.000136	0.00163	CbGpPWpGaD
Dextrothyroxine—Palpitations—Epirubicin—ovarian cancer	0.000135	0.00175	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000135	0.00161	CbGpPWpGaD
Dextrothyroxine—Asthenia—Docetaxel—ovarian cancer	0.000133	0.00172	CcSEcCtD
Dextrothyroxine—Convulsion—Epirubicin—ovarian cancer	0.000133	0.00172	CcSEcCtD
Dextrothyroxine—Pruritus—Docetaxel—ovarian cancer	0.000131	0.0017	CcSEcCtD
Dextrothyroxine—Arthralgia—Epirubicin—ovarian cancer	0.00013	0.00169	CcSEcCtD
Dextrothyroxine—Agitation—Doxorubicin—ovarian cancer	0.00013	0.00169	CcSEcCtD
Dextrothyroxine—Anxiety—Epirubicin—ovarian cancer	0.00013	0.00168	CcSEcCtD
Dextrothyroxine—Nausea—Paclitaxel—ovarian cancer	0.00013	0.00168	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00013	0.00155	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—SOD1—ovarian cancer	0.000128	0.00153	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PPP2R1A—ovarian cancer	0.000128	0.00152	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Docetaxel—ovarian cancer	0.000127	0.00164	CcSEcCtD
Dextrothyroxine—Confusional state—Epirubicin—ovarian cancer	0.000126	0.00163	CcSEcCtD
Dextrothyroxine—Palpitations—Doxorubicin—ovarian cancer	0.000125	0.00162	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000123	0.00147	CbGpPWpGaD
Dextrothyroxine—Shock—Epirubicin—ovarian cancer	0.000123	0.00159	CcSEcCtD
Dextrothyroxine—Convulsion—Doxorubicin—ovarian cancer	0.000123	0.00159	CcSEcCtD
Dextrothyroxine—Tachycardia—Epirubicin—ovarian cancer	0.000122	0.00158	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000121	0.00157	CcSEcCtD
Dextrothyroxine—Arthralgia—Doxorubicin—ovarian cancer	0.000121	0.00156	CcSEcCtD
Dextrothyroxine—Anxiety—Doxorubicin—ovarian cancer	0.00012	0.00156	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000119	0.00142	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—YAP1—ovarian cancer	0.000119	0.00142	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—YAP1—ovarian cancer	0.000119	0.00142	CbGpPWpGaD
Dextrothyroxine—Vomiting—Docetaxel—ovarian cancer	0.000118	0.00153	CcSEcCtD
Dextrothyroxine—Rash—Docetaxel—ovarian cancer	0.000117	0.00151	CcSEcCtD
Dextrothyroxine—Dermatitis—Docetaxel—ovarian cancer	0.000117	0.00151	CcSEcCtD
Dextrothyroxine—Confusional state—Doxorubicin—ovarian cancer	0.000117	0.00151	CcSEcCtD
Dextrothyroxine—Headache—Docetaxel—ovarian cancer	0.000116	0.0015	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—ESR1—ovarian cancer	0.000115	0.00138	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—ESR1—ovarian cancer	0.000115	0.00138	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000114	0.00148	CcSEcCtD
Dextrothyroxine—Shock—Doxorubicin—ovarian cancer	0.000114	0.00147	CcSEcCtD
Dextrothyroxine—Insomnia—Epirubicin—ovarian cancer	0.000113	0.00146	CcSEcCtD
Dextrothyroxine—Tachycardia—Doxorubicin—ovarian cancer	0.000113	0.00146	CcSEcCtD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000112	0.00134	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000112	0.00134	CbGpPWpGaD
Dextrothyroxine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000112	0.00145	CcSEcCtD
Dextrothyroxine—Dyspnoea—Epirubicin—ovarian cancer	0.000111	0.00144	CcSEcCtD
Dextrothyroxine—Nausea—Docetaxel—ovarian cancer	0.00011	0.00143	CcSEcCtD
Dextrothyroxine—Fatigue—Epirubicin—ovarian cancer	0.000108	0.0014	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000106	0.00127	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000105	0.00137	CcSEcCtD
Dextrothyroxine—Insomnia—Doxorubicin—ovarian cancer	0.000105	0.00136	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—PGR—ovarian cancer	0.000104	0.00124	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—PGR—ovarian cancer	0.000104	0.00124	CbGpPWpGaD
Dextrothyroxine—Dyspnoea—Doxorubicin—ovarian cancer	0.000103	0.00134	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Epirubicin—ovarian cancer	0.000103	0.00133	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000103	0.00123	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000102	0.00132	CcSEcCtD
Dextrothyroxine—Fatigue—Doxorubicin—ovarian cancer	9.97e-05	0.00129	CcSEcCtD
Dextrothyroxine—Urticaria—Epirubicin—ovarian cancer	9.93e-05	0.00129	CcSEcCtD
Dextrothyroxine—Body temperature increased—Epirubicin—ovarian cancer	9.88e-05	0.00128	CcSEcCtD
Dextrothyroxine—Abdominal pain—Epirubicin—ovarian cancer	9.88e-05	0.00128	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—PARP1—ovarian cancer	9.65e-05	0.00115	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—PARP1—ovarian cancer	9.65e-05	0.00115	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Doxorubicin—ovarian cancer	9.53e-05	0.00123	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—YAP1—ovarian cancer	9.5e-05	0.00114	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.46e-05	0.00123	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.4e-05	0.00112	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—CAV1—ovarian cancer	9.38e-05	0.00112	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.27e-05	0.00111	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	9.23e-05	0.0011	CbGpPWpGaD
Dextrothyroxine—Urticaria—Doxorubicin—ovarian cancer	9.19e-05	0.00119	CcSEcCtD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	9.17e-05	0.0011	CbGpPWpGaD
Dextrothyroxine—Abdominal pain—Doxorubicin—ovarian cancer	9.15e-05	0.00118	CcSEcCtD
Dextrothyroxine—Body temperature increased—Doxorubicin—ovarian cancer	9.15e-05	0.00118	CcSEcCtD
Dextrothyroxine—Asthenia—Epirubicin—ovarian cancer	8.97e-05	0.00116	CcSEcCtD
Dextrothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	8.91e-05	0.00107	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	8.89e-05	0.00106	CbGpPWpGaD
Dextrothyroxine—Pruritus—Epirubicin—ovarian cancer	8.85e-05	0.00115	CcSEcCtD
Dextrothyroxine—Diarrhoea—Epirubicin—ovarian cancer	8.55e-05	0.00111	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CG—ovarian cancer	8.54e-05	0.00102	CbGpPWpGaD
Dextrothyroxine—Asthenia—Doxorubicin—ovarian cancer	8.3e-05	0.00108	CcSEcCtD
Dextrothyroxine—Pruritus—Doxorubicin—ovarian cancer	8.18e-05	0.00106	CcSEcCtD
Dextrothyroxine—Vomiting—Epirubicin—ovarian cancer	7.95e-05	0.00103	CcSEcCtD
Dextrothyroxine—Diarrhoea—Doxorubicin—ovarian cancer	7.92e-05	0.00103	CcSEcCtD
Dextrothyroxine—Rash—Epirubicin—ovarian cancer	7.88e-05	0.00102	CcSEcCtD
Dextrothyroxine—Dermatitis—Epirubicin—ovarian cancer	7.88e-05	0.00102	CcSEcCtD
Dextrothyroxine—Headache—Epirubicin—ovarian cancer	7.83e-05	0.00101	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—PPP2R1A—ovarian cancer	7.82e-05	0.000935	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—PPP2R1A—ovarian cancer	7.82e-05	0.000935	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—FASN—ovarian cancer	7.74e-05	0.000925	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—SLC5A5—ovarian cancer	7.62e-05	0.00091	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CD—ovarian cancer	7.51e-05	0.000897	CbGpPWpGaD
Dextrothyroxine—Nausea—Epirubicin—ovarian cancer	7.43e-05	0.000962	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—SLC2A1—ovarian cancer	7.36e-05	0.000879	CbGpPWpGaD
Dextrothyroxine—Vomiting—Doxorubicin—ovarian cancer	7.36e-05	0.000953	CcSEcCtD
Dextrothyroxine—Rash—Doxorubicin—ovarian cancer	7.29e-05	0.000945	CcSEcCtD
Dextrothyroxine—Dermatitis—Doxorubicin—ovarian cancer	7.29e-05	0.000944	CcSEcCtD
Dextrothyroxine—SLCO1B1—Metabolism—NME2—ovarian cancer	7.25e-05	0.000867	CbGpPWpGaD
Dextrothyroxine—Headache—Doxorubicin—ovarian cancer	7.25e-05	0.000939	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—CYP1B1—ovarian cancer	7.05e-05	0.000843	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.03e-05	0.00084	CbGpPWpGaD
Dextrothyroxine—Nausea—Doxorubicin—ovarian cancer	6.87e-05	0.00089	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CB—ovarian cancer	6.54e-05	0.000782	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PPP2R1A—ovarian cancer	6.25e-05	0.000747	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.15e-05	0.000735	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—IL2—ovarian cancer	6.01e-05	0.000718	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—MYC—ovarian cancer	5.99e-05	0.000715	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—MYC—ovarian cancer	5.99e-05	0.000715	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—ABCB1—ovarian cancer	5.81e-05	0.000694	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—TYMS—ovarian cancer	5.7e-05	0.000682	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—ESR1—ovarian cancer	5.54e-05	0.000662	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—ESR1—ovarian cancer	5.54e-05	0.000662	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—VEGFA—ovarian cancer	5.11e-05	0.00061	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—NRAS—ovarian cancer	5.04e-05	0.000603	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.01e-05	0.000599	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—MAPK3—ovarian cancer	4.83e-05	0.000577	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.69e-05	0.00056	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CYTB—ovarian cancer	4.67e-05	0.000558	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—MAPK1—ovarian cancer	4.6e-05	0.000549	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—CAV1—ovarian cancer	4.6e-05	0.000549	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.57e-05	0.000546	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.53e-05	0.000541	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—KRAS—ovarian cancer	4.34e-05	0.000519	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CG—ovarian cancer	4.19e-05	0.0005	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—BRIP1—ovarian cancer	4.08e-05	0.000488	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	4.08e-05	0.000488	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CA—ovarian cancer	3.99e-05	0.000477	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—TP53—ovarian cancer	3.86e-05	0.000461	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—HRAS—ovarian cancer	3.69e-05	0.000441	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CD—ovarian cancer	3.68e-05	0.00044	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.58e-05	0.000427	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—AKT1—ovarian cancer	3.26e-05	0.000389	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CB—ovarian cancer	3.21e-05	0.000383	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.98e-05	0.000356	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—MAPK3—ovarian cancer	2.96e-05	0.000354	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—MAPK3—ovarian cancer	2.96e-05	0.000354	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—MYC—ovarian cancer	2.88e-05	0.000344	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—MYC—ovarian cancer	2.88e-05	0.000344	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PTEN—ovarian cancer	2.77e-05	0.000331	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—YAP1—ovarian cancer	2.74e-05	0.000327	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.71e-05	0.000324	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.38e-05	0.000285	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—FASN—ovarian cancer	2.23e-05	0.000267	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	2.2e-05	0.000262	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	2.12e-05	0.000254	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.08e-05	0.000248	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	2.03e-05	0.000243	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—AKT1—ovarian cancer	2e-05	0.000239	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—AKT1—ovarian cancer	2e-05	0.000239	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CA—ovarian cancer	1.96e-05	0.000234	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.8e-05	0.000216	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.79e-05	0.000215	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.67e-05	0.0002	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.64e-05	0.000197	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—AKT1—ovarian cancer	1.6e-05	0.000191	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.33e-05	0.000158	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.27e-05	0.000151	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	1.21e-05	0.000144	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	1.06e-05	0.000127	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	9.25e-06	0.000111	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PTEN—ovarian cancer	7.99e-06	9.55e-05	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	5.64e-06	6.74e-05	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKT1—ovarian cancer	4.61e-06	5.51e-05	CbGpPWpGaD
